Functional interaction between opioid and cannabinoid receptors in drug self-administration.

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011

Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice

Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,628

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913

Determination and characterization of a cannabinoid receptor in rat brain

Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 2×

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159

Naltrexone in the Treatment of Alcohol Dependence

Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,762

Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene

Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722

A second endogenous cannabinoid that modulates long-term potentiation

Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496

Role of different brain structures in the behavioural expression of WIN 55,212‐2 withdrawal in mice

Castañé, A., Maldonado, R. J., & Valverde, O. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705882 · Cited by 31

CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats

Wills, K. L., Vemuri, K., Kalmar, A., Lee, A., Limebeer, C. L., Makriyannis, A., & Parker, L. A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3575-5 · Cited by 29

Cellular and behavioral basis of cannabinioid and opioid interactions: Implications for opioid dependence and withdrawal

Mohammadkhani, A., & Borgland, S. L. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24770 · Cited by 29

Alterations in Rat Accumbens Endocannabinoid and GABA Content during Fentanyl Treatment: The Role of Ghrelin

Šustková-Fišerová, M., Charalambous, C., Havlickova, T., Lapka, M., Jerabek, P., Puskina, N., & Syslová, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112486 · Cited by 29

The endocannabinoid system and related lipids as potential targets for the treatment of migraine‐related pain

Greco, R., Demartini, C., Zanaboni, A. M., Francavilla, M., Icco, R. D., Ahmad, L., & Tassorelli, C. (2022) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14267 · Cited by 45

Identification of Candidate Genes and Gene Networks Specifically Associated with Analgesic Tolerance to Morphine

Tapocik, J. D., Letwin, N. E., Mayo, C. L., Frank, B. C., Luu, T., Oduaran, O. H., House, C. D., Williams, R., Elmer, G. I., & Lee, N. H. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4020-08.2009 · Cited by 30

Neuroinflammation as a possible link between cannabinoids and addiction

Rodrigues, L. C. M., Gobira, P. H., de Oliveira, A. C., Pelição, R., Teixeira, A. L., Moreira, F. A., & Campos, A. C. (2013) · Acta Neuropsychiatrica · doi:10.1017/neu.2014.24 · Cited by 29

Behavioral effects of fatty acid amide hydrolase inhibition on morphine withdrawal symptoms

Shahidi, ‬., & Hasanein, P. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.06.019 · Cited by 30

Repeated administration with δ9- tetrahydrocannabinol regulates µ-opioid receptor density in the rat brain

Corchero, J., Oliva, J. M., Garcı́a-Lecumberri, C., Martı́n, S., Ambrosio, E., & Manzanares, J. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104040237 · Cited by 28

Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans

Ranganathan, M., Carbuto, M., Braley, G., Elander, J., Perry, E. B., Pittman, B. P., Radhakrishnan, R., Sewell, R. A., & D’Souza, D. C. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001830 · Cited by 27

Biomarkers of the Endocannabinoid System in Substance Use Disorders

Navarrete, F., García‐Gutiérrez, M. S., Gasparyan, A., Navarro, D., Lopez‐Picon, F. R., Morcuende, Á., Femenía, T., & Manzanares, J. (2022) · Biomolecules · doi:10.3390/biom12030396 · Cited by 26

CB1 receptors regulate alcohol-seeking behavior and alcohol self-administration of alcohol-preferring (P) rats

Getachew, B., Hauser, S. R., Dhaher, R., Katner, S. N., Bell, R. L., Oster, S. M., McBride, W. J., & Rodd, Z. A. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.11.006 · Cited by 27

Effects of rimonabant on the reinstatement of nicotine-conditioned place preference by drug priming in rats

Biała, G., Budzyńska, B., & Staniak, N. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.042 · Cited by 27

Effect of Pharmacological Modulation of the Endocannabinoid System on Opiate Withdrawal: A Review of the Preclinical Animal Literature

Wills, K. L., & Parker, L. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00187 · Cited by 26

Role of endocannabinoids in regulating drug dependence

Parolaro, D. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s976 · Cited by 26

Ultra-low dose naltrexone enhances cannabinoid-induced antinociception

Paquette, J. J., & Olmstead, M. C. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200512000-00001 · Cited by 26

Expectancy Modulation of Opioid Neurotransmission

Peciña, M., & Zubieta, J.-K. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.02.003 · Cited by 27

Alleviative effects of Cannabis flower on migraine and headache

Stith, S. S., Diviant, J. P., Brockelman, F., Keeling, K., Hall, B., Lucern, S., & Vigil, J. M. (2020) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2020.07.004 · Cited by 26

Differential effect of opioid and cannabinoid receptor blockade on heroin‐seeking reinstatement and cannabinoid substitution in heroin‐abstinent rats

Fattore, L., Spano, M. S., Melis, V., Fadda, P., & Fratta, W. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01459.x · Cited by 26

κ‐ and δ‐opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1receptor knockout mice

Urigüen, L., Berrendero, F., Ledent, C. A., Maldonado, R. J., & Manzanares, J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04372.x · Cited by 25

Acetaldehyde as a drug of abuse: insight into AM281 administration on operant-conflict paradigm in rats

Plescia, F., Brancato, A., Marino, R. A. M., & Cannizzaro, C. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00064 · Cited by 25

Crosstalk between Opioid and Anti-Opioid Systems: An Overview and Its Possible Therapeutic Significance

Gibuła‐Tarłowska, E., & Kotlinska, J. H. (2020) · Biomolecules · doi:10.3390/biom10101376 · Cited by 25

A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena

Solbrig, M. V., Adrian, R., Baratta, J. L., Piomelli, D., & Giuffrida, A. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.02.017 · Cited by 24

Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acids

Hermes, D. J., Jacobs, I. R., Key, M. C., League, A. F., Yadav-Samudrala, B. J., Xu, C., McLane, V. D., Nass, S. R., Jiang, W., Meeker, R. B., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01971-6 · Cited by 25

The Effects of Repeated Morphine Treatment on the Endogenous Cannabinoid System in the Ventral Tegmental Area

Zhang, H., Lipinski, A. A., Liktor‐Busa, E., Smith, A. F., Moutal, A., Khanna, R., Langlais, P. R., Largent‐Milnes, T. M., & Vanderah, T. W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.632757 · Cited by 24

Molecular Mechanisms of Cannabis Signaling in the Brain

Ronan, P. J., Wongngamnit, N., & Beresford, T. P. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.002 · Cited by 25

Negative allosteric modulation of CB1 cannabinoid receptor signaling suppresses opioid-mediated reward

Iyer, V., Rangel‐Barajas, C., Woodward, T. J., Kulkarni, A., Cantwell, L., Crystal, J. D., Mackie, K., Rebec, G. V., Thakur, G. A., & Hohmann, A. G. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106474 · Cited by 20

Caffeine drinking potentiates cannabinoid transmission in the striatum: Interaction with stress effects

Rossi, S., Chiara, V. D., Musella, A., Mataluni, G., Sacchetti, L., Siracusano, A., Bernardi, G., Usiello, A., & Centonze, D. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.10.013 · Cited by 22

Cannabinoid-induced tolerance is associated with a CB1 receptor G protein coupling switch that is prevented by ultra-low dose rimonabant

Paquette, J. J., Wang, H.-Y., Bakshi, K. P., & Olmstead, M. C. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282f15890 · Cited by 22

Determination of endocannabinoid receptor antagonist SR141716 (rimonabant) in plasma by liquid chromatograph tandem mass spectrometry

McCulloch, M., Zhou, X., Xu, Y., Brunell, S. C., & SPEAR, L. P. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.01.020 · Cited by 22

Effect of opioid and cannabinoid receptor antagonism on orphanin FQ-induced hyperphagia in rats

Pietras, T. A., & Rowland, N. E. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01551-0 · Cited by 22

Psychosocial and Pharmacological Interventions for the Treatment of Cannabis Use Disorder

Sabioni, P., & Foll, B. L. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.17202 · Cited by 22

The role of catecholamines in modulating responses to stress: Sex‐specific patterns, implications, and therapeutic potential for post‐traumatic stress disorder and opiate withdrawal

Ross, J. A., & Bockstaele, E. J. V. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14714 · Cited by 20

Chronic cannabinoid exposure produces tolerance to the dopamine releasing effects of WIN 55,212–2 and heroin in adult male rats

Gomez, D. M., Everett, T. J., Hamilton, L. R., Ranganath, A., Cheer, J. F., & Oleson, E. B. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108374 · Cited by 21

Lipids and drugs of abuse

Hillard, C. J. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.004 · Cited by 21

Inhibition of forebrain μ-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves μ-opioid receptors

Zádor, F., Ötvös, F., Benyhe, S., Zimmer, A., & Páldy, E. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.05.015 · Cited by 20

Cannabinoids in Health and Disease

Meccariello, R., & Chianese, R. (2016) · InTech eBooks · doi:10.5772/61595 · Cited by 22

Effects of centrally administered endocannabinoids and opioids on orofacial pain perception in rats

Zubrzycki, M., Janecka, A. E., Liebold, A., Ziegler, M., & Zubrzycka, M. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13970 · Cited by 21

Sex differences in the effect of cannabinoid type 1 receptor deletion on locus coeruleus‐norepinephrine neurons and corticotropin releasing factor‐mediated responses

Wyrofsky, R. R., Reyes, B. A. S., Yu, D., Kirby, L. G., & Bockstaele, E. J. V. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14103 · Cited by 20

Possible involvement of endocannabinoids in the increase of morphine consumption in maternally deprived rat

Naudon, L., Piscitelli, F., Bruno Giros, A., Marzo, V. D., & Daugé, V. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.10.008 · Cited by 20

Interaction of Cannabis Use and Aging: From Molecule to Mind

Yoo, H. B., DiMuzio, J. M., & Filbey, F. M. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1665218 · Cited by 21

Effects of Cannabinoid Exposure during Adolescence on the Conditioned Rewarding Effects of WIN 55212-2 and Cocaine in Mice: Influence of the Novelty-Seeking Trait

Rodríguez‐Arias, M., Roger-Sánchez, C., Vilanova, I., Revert, N., Manzanedo, C., Miñarro, J., & Aguilar, M. A. (2015) · Neural Plasticity · doi:10.1155/2016/6481862 · Cited by 18

Alleviation of opioid withdrawal by cannabis and delta-9-tetrahydrocannabinol: A systematic review of observational and experimental human studies

Aquino, J. P. D., Bahji, A., Gómez, Ó., & Sofuoglu, M. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109702 · Cited by 21

Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats

Wright, F., & Rodgers, R. J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2916-5 · Cited by 18

Evaluation of the reinforcing effects of the cannabinoid CB1 receptor antagonist, SR141716, in rhesus monkeys

Beardsley, P. M., Dance, M. E., Balster, R. L., & Munzar, P. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01597-7 · Cited by 18

Effects of prenatal immune activation and peri-adolescent stress on amphetamine-induced conditioned place preference in the rat

Richtand, N. M., Ahlbrand, R. A., Horn, P. S., Chambers, B., Davis, J. F., & Benoit, S. C. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2646-8 · Cited by 17

Opioid and Endocannabinoid System in Orofacial Pain

Zubrzycki, M., Stasiołek, M., & Zubrzycka, M. (2019) · Physiological Research · doi:10.33549/physiolres.934159 · Cited by 19

Gender differences in proenkephalin gene expression response to ∆9-tetrahydrocannabinol in the hypothalamus of the rat

Corchero, J., Fuentes, J. A., & Manzanares, J. (2002) · Journal of Psychopharmacology · doi:10.1177/026988110201600401 · Cited by 17

Pharmacological Interventions for Obesity: Current and Future Targets

Bocarsly, M. E. (2018) · Current Addiction Reports · doi:10.1007/s40429-018-0204-0 · Cited by 16

The endogenous cannabinoid system and drug addiction: 20 years after the discovery of the CB1 receptor

de Fonseca, F. R., & Schneider, M. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00116.x · Cited by 18

Preimplantation Mouse Embryo Is a Target for Opioid Ligand-Receptor Signaling1

Chen, Y., Kong, S., Tang, X., Fu, Y., Wang, B. J., Zhang, S., & Wang, H. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.118083 · Cited by 16

Opioids and addiction: Emerging pharmaceutical strategies for reducing reward and opponent processes

Bryant, C. D., Zaki, P. A., Carroll, F. I., & Evans, C. J. (2005) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2005.08.006 · Cited by 16

Elevation of pentylenetetrazole‐induced seizure threshold in cholestatic mice: Interaction between opioid and cannabinoid systems

Shafaroodi, H., Ghasemi, M., & Dehpour, A. R. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05101.x · Cited by 16

Cannabinoids and opioids share cAMP pathway in rat splenocytes

Massi, P., Vaccani, A., Rubino, T., & Parolaro, D. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.09.006 · Cited by 16

Daily Δ9-Tetrahydrocannabinol and Withdrawal Increase Dopamine D1-D2 Receptor Heteromer to Mediate Anhedonia- and Anxiogenic-like Behavior Through a Dynorphin and Kappa Opioid Receptor Mechanism

Hasbi, A., Madras, B., & George, S. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2022.07.003 · Cited by 13

Cannabidiol regulates behavioral and brain alterations induced by spontaneous alcohol withdrawal

Gasparyan, A., Navarrete, F., Navarro, D., & Manzanares, J. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109549 · Cited by 15

Cannabis and Cannabinoids in Multiple Sclerosis: From Experimental Models to Clinical Practice—A Review

Sîrbu, C. A., Georgescu, R., Pleşa, C., Păunescu, A., Ţânţu, M. M., Nicolae, A. C., Caloianu, I., & Mitrică, M. (2022) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001568 · Cited by 15

Neurophysiology of corneal neuropathic pain and emerging pharmacotherapeutics

Asiedu, K. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25285 · Cited by 15

Endocannabinoids, through opioids and prostaglandins, contribute to fever induced by key pyrogenic mediators

Fraga, D., Zanoni, C. I. S., Zampronio, A. R., Parada, C. A., Rae, G. A., & de Souza, G. E. P. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.08.014 · Cited by 15

Open-label pilot study of injectable naltrexone for cannabis dependence

Notzon, D. P., Kelly, M. A., Choi, C. J., Pavlicová, M., Mahony, A. L., Brooks, D. J., Mariani, J. J., & LEVIN, F. R. (2018) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2017.1423321 · Cited by 15

Cannabinoid-1 receptor gene deletion has a compartment-specific affect on the dendritic and axonal availability of μ-opioid receptors and on dopamine axons in the mouse nucleus accumbens

Lane, D., Chan, J., Lupica, C. R., & Pickel, V. M. (2010) · Synapse · doi:10.1002/syn.20807 · Cited by 15

Effects of caffeine on striatal neurotransmission: Focus on cannabinoid CB1 receptors

Rossi, S., Chiara, V. D., Musella, A., Mataluni, G., Sacchetti, L., Siracusano, A., Bernardi, G., Usiello, A., & Centonze, D. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900237 · Cited by 15

Interactions between cannabinoid and opioid receptors in a mouse model of diabetic neuropathy

Toniolo, E. F., Gupta, A., Franciosi, A. C., Gomes, I., Devi, L. A., & Dale, C. S. (2021) · Pain · doi:10.1097/j.pain.0000000000002527 · Cited by 15

PPARα/CB1 receptor dual ligands as a novel therapy for alcohol use disorder: Evaluation of a novel oleic acid conjugate in preclinical rat models

Alén, F., Decara, J. M., Brunori, G., You, Z., Bühler, K., López‐Moreno, J. A., Cippitelli, A., Pavón, F. J., Suárez, J., Gardner, E. L., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.008 · Cited by 14

Neuropsychopharmacologie du delta-9-tétrahydrocannabinol (THC)

Costentin, J. (2008) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2008.07.003 · Cited by 15

Adolescent self-administration of the synthetic cannabinoid receptor agonist JWH-018 induces neurobiological and behavioral alterations in adult male mice

Margiani, G., Castelli, M. P., Pintori, N., Frau, R., Ennas, M. G., Zottola, A. C. P., Orrù, V., Serra, V., Fiorillo, E., Fadda, P., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06191-9 · Cited by 13

The role of ghrelin/GHS-R1A signaling in nonalcohol drug addictions

Sustkova-Fiserova, M., Charalambous, C., Khryakova, A., Certilina, A., Lapka, M., & Šlamberová, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020761 · Cited by 12

Molecules Acting on CB1 Receptor and their Effects on Morphine Withdrawal In Vitro

Capasso, A., & Gallo, C. (2009) · The Open Biochemistry Journal · doi:10.2174/1874091x00903010078 · Cited by 12

Comparative effects of pulmonary and parenteral Δ9-tetrahydrocannabinol exposure on extinction of opiate-induced conditioned aversion in rats

Manwell, L. A., & Mallet, P. E. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3798-5 · Cited by 12

Rimonabant blocks the expression but not the development of locomotor sensitization to nicotine in rats

Kelsey, J. E., & Calabro, S. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0913-x · Cited by 12

Le système opioïde endogène et l’addiction aux drogues

Maldonado, R. J. (2010) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2009.12.001 · Cited by 26

Endocannabinoids and addiction memory: Relevance to methamphetamine/morphine abuse

Alizamini, M. M., Li, Y., Zhang, J., Liang, J., & Haghparast, A. (2022) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2022.2039408 · Cited by 10

Cannabinoids and General Anesthetics: Revisiting Molecular Mechanisms of Their Pharmacological Interactions

Echeverria-Villalobos, M., Fabian, C. A., Mitchell, J., Mazzota, E., Fiorda‐Diaz, J., Noon, K., & Weaver, T. E. (2024) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000007313 · Cited by 10

The endocannabinoid system: critical for the neurotrophic action of psychotropic drugs

Hassanzadeh, P. (2010) · Biomedical Reviews · doi:10.14748/bmr.v21.45 · Cited by 10

Roles of cannabinoid CB1 and CB2 receptors in the modulation of psychostimulant responses

Gobira, P. H., Joca, S. R. L., & Moreira, F. A. (2022) · Acta Neuropsychiatrica · doi:10.1017/neu.2022.23 · Cited by 10

Effects of co-administration of 2-arachidonylglycerol (2-AG) and a selective µ-opioid receptor agonist into the nucleus accumbens on high-fat feeding behaviors in the rat

Parker, K. E., McCall, J. G., McGuirk, S. R., Trivedi, S., Miller, D. K., & Will, M. J. (2015) · Brain Research · doi:10.1016/j.brainres.2015.06.010 · Cited by 10

Cannabinoids for Pain Management

Mosley, C. I., Gaynor, J. S., Cital, S. N., & Brassard, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-68317-7_5 · Cited by 12

Development and validation of a high-performance liquid chromatographic method for bioanalytical application with rimonabant

Bhaumik, U. K., Ghosh, A., Chatterjee, B., Sengupta, P., Darbar, S., Roy, B., Nandi, U., & Pal, T. K. (2009) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2009.01.032 · Cited by 9

Neural Basis of Pleasure and Reward

Knapp, C. M., & Kornetsky, C. H. (2009) · Wiley eBooks · doi:10.1002/9780470478509.neubb002040 · Cited by 9

Loren Parsons' contribution to addiction neurobiology

Luca, M. A. D., Buczynski, M. W., & Chiara, G. D. (2018) · Addiction Biology · doi:10.1111/adb.12642 · Cited by 8

The role of cannabinoid 1 receptor in the nucleus accumbens on tramadol induced conditioning and reinstatement

Sadeghi-Adl, M., Sadat‐Shirazi, M., Shahini, F., Akbarabadi, A., Khalifeh, S., Borzabadi, S., Nasehi, M., & Zarrindast, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118430 · Cited by 8

The effect of AM281, a cannabinoid antagonist, on memory performance during spontaneous morphine withdrawal in mice.

Vaseghi, G., Rabbani, M., & Hajhashemi, V. (2013) · Europe PMC (PubMed Central) · Cited by 8

∆9-Tetrahydrocannabinol Decreases NOP Receptor Density and mRNA Levels in Human SH-SY5Y Cells

Cannarsa, R., Carretta, D., Lattanzio, F., Candeletti, S., & Romualdi, P. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9552-0 · Cited by 8

Treatment of acute cannabinoid overdose with naloxone infusion

Richards, J. R., Schandera, V., & Elder, J. W. (2017) · Toxicology Communications · doi:10.1080/24734306.2017.1392715 · Cited by 8

Bivalent and bitopic ligands of the opioid receptors: The prospects of a dual approach

Hovah, M. E. L., & Holzgrabe, U. (2024) · Medicinal Research Reviews · doi:10.1002/med.22050 · Cited by 7

Effects of the cannabinoid CB1-receptor neutral antagonist AM4113 and antagonist/inverse agonist rimonabant on fentanyl discrimination in male rats

Alkhelb, D. A., Kirunda, A., Ho, T. C., Makriyannis, A., & Desai, R. I. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109646 · Cited by 6

Cannabinoid regulation of opiate motivational processing in the mesolimbic system: the integrative roles of amygdala, prefrontal cortical and ventral hippocampal input pathways

Laviolette, S. R. (2016) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2016.10.004 · Cited by 6

Cannabinoid CB1 receptor and mu-opioid receptor interaction: new insights from conditional knockout mice

Alton, H., Linz, E., Bi, G., Soler‐Cedeño, O., Maras, M., & Xi, Z. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02245-6 · Cited by 5

Acute kappa opioid receptor blocking disrupts the pro-cognitive effect of cannabidiol in neuropathic rats

Boccella, S., Fusco, A., Ricciardi, F., Morace, A. M., Bonsale, R., Perrone, M., Marabese, I., Gregorio, D. D., Belardo, C., Posa, L., et al. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110265 · Cited by 5

Evaluation of the abuse potential of AM281, a new synthetic cannabinoid CB1 receptor antagonist

Botanas, C. J., de la Peña, J. B., Peña, I. J. D., Tampus, R., Kim, H. J., Yoon, S. S., Seo, J., Jeong, E. J., & Cheong, J. H. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.10.004 · Cited by 5

Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception

Godoi, M. M., Zangrossi, H., da Cunha, J. M., & Zanoveli, J. M. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172938 · Cited by 5

Is cannabinoid transmission involved in rewarding properties of drugs of abuse?

Parolaro, D., & Rubino, T. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704826 · Cited by 5

The role of endocannabinoids in the control of eating disorders

Milano, W., Tecce, M. F., & Capasso, A. (2017) · Diseases and Disorders · doi:10.15761/jdd.1000103 · Cited by 5

Reply to the letter to the editor “Long‐term cannabinoid receptor (CB1) blockade in obesity: Implications for the development of colorectal cancer”

Santoro, A., Gazzerro, P., Malfitano, A. M., Pisanti, S., Laezza, C., & Bifulco, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23507 · Cited by 5

Biphasic regulation of the acute μ-withdrawal and CCk-8 contracture responses by the ORL-1 system in guinea pig ileum

Marini, P., Romanelli, L., Valeri, D., Cascio, M. G., Tucci, P., VALERI, P., & Palmery, M. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.08.004 · Cited by 4

CB1 Agonism Alters Addiction-Related Behaviors in Mice Lacking Mu or Delta Opioid Receptors

Roeckel, L.-A., Massotte, D., Olmstead, M. C., & Befort, K. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00630 · Cited by 4

Bhanga as an activity potentiater in Ayurvedic classics and Indian alchemy (Rasashastra): A critical review

Tavhare, S. D., & Acharya, R. (2016) · International Journal of Ayurvedic Medicine · doi:10.47552/ijam.v7i3.829 · Cited by 4

Endocannabinoid Signaling in Reward and Addiction: From Homeostasis to Pathology

Laredo, S. A., Marrs, W., & Parsons, L. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_10 · Cited by 5

The Endocannabinoid System and the Therapeutic Potential of Cannabinoids

Martin, B. R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-947-9_6 · Cited by 4

The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes

Kracke, G. R., Stoneking, S. P., Ball, J. M., Tilghman, B. M., Washington, C. C., Hotaling, K. A., Johnson, J. O., & Tobias, J. D. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0201-7 · Cited by 4

CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats

Navarro, M., Chowen, J., Carrera, M. R. A., del Arco, I., Villanúa, M. A., Martin, Y., Roberts, A. J., Koob, G. F., & de Fonseca, F. R. (1998) · NeuroReport · doi:10.1097/00001756-199810260-00012 · Cited by 152

Cannabinoid receptor antagonist reduces heroin self-administration only in dependent rats

Navarro, M., Carrera, M. R. A., del Arco, I., Trigo, J. M., Koob, G. F., & de Fonseca, F. R. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.08.022 · Cited by 34

Reduction of opioid dependence by the CB1 antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction

Nieto, M. M., Pommier, B., Tzavara, E. T., Caneparo, A., Nascimento, S. D., Fur, G. L., Roques, B. P., & Noble, F. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703990 · Cited by 111

Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.

Lichtman, A. H., Sheikh, S. M., Loh, H. H., & Martin, B. R. (2001) · PubMed · Cited by 156

Cannabinoid Modulation of Opiate Reinforcement through the Ventral Striatopallidal Pathway

Caillé, S., & Parsons, L. H. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300848 · Cited by 122